Ultragenyx Pharmaceutical Inc.
Creatine prodrugs, compositions and methods of use thereof

Last updated:

Abstract:

The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.

Status:
Grant
Type:

Utility

Filling date:

3 Dec 2018

Issue date:

17 May 2022